EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes

Maria Elisa Giuliani iD, Giorgia Bigossi iD, Giovanni Lai, Serena Marcozzi iD, Dario Brunetti iD, Marco Malavolta iD

Marine Drugs · 2024

DOI: 10.3390/md22050210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, 2024. Verfasst von Maria Elisa Giuliani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Technology Center for Aging Research and Geriatric Mouse Clinic, IRCCS INRCA, 60121 Ancona, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Aquatic Organisms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Ministero dell'Università e della Ricerca, Next Generation EU—“Age-It—Ageing well in an ageing society” project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ageing represents a main risk factor for several pathologies. Among them, cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM) are predominant in the elderly population and often require prolonged use of multiple drugs due to their chronic nature and the high proportion of co-morbidities. Hence, research is constantly looking for novel, effective molecules to treat CVD and T2DM with minimal side effects. Marine active compounds, holding a great diversity of chemical structures and biological properties, represent interesting therapeutic candidates to treat these age-related diseases. This review summarizes the current state of research on marine compounds for the treatment of CVD and T2DM, from pre-clinical studies to clinical investigations and approved drugs, highlighting the potential of marine compounds in the development of new therapies, together with the limitations in translating pre-clinical results into human application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes Mellitus, Type 2Aquatic OrganismsHumansAnimalsHypoglycemic AgentsAgingBiological ProductsDrug Evaluation, Preclinical

Stichwörter der Autor:innen

ageingcardiovascular diseaseclinical trialsin vivo studiesmarine compoundstype 2 diabetes mellitus

Substanzen

Hypoglycemic AgentsBiological Products

Autor:innen und Institutionen

  • Advanced Technology Center for Aging Research and Geriatric Mouse Clinic, IRCCS INRCA, 60121 Ancona, Italy.
  • Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico "Carlo Besta", 20126 Milano, Italy.
  • Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

ORCID-Profile: Maria Elisa Giuliani, Giorgia Bigossi, Serena Marcozzi, Dario Brunetti, Marco Malavolta

Förderung

  • Italian Ministry of Health
  • Ministero dell'Università e della Ricerca
  • Next Generation EU—“Age-It—Ageing well in an ageing society” project

Zitieren

APA

Giuliani, M. E., Bigossi, G., Lai, G., Marcozzi, S., Brunetti, D., & Malavolta, M. (2024). Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes. Marine Drugs. https://doi.org/10.3390/md22050210

Vancouver

Giuliani ME, Bigossi G, Lai G, Marcozzi S, Brunetti D, Malavolta M. Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes. Marine Drugs. 2024. doi:10.3390/md22050210

BibTeX
@article{Giuliani2024,
  author = {Giuliani, Maria Elisa and Bigossi, Giorgia and Lai, Giovanni and Marcozzi, Serena and Brunetti, Dario and Malavolta, Marco},
  title = {Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22050210}
}
Kostenlos starten →